Insel P A
Am J Physiol. 1984 Jul;247(1 Pt 1):E53-8. doi: 10.1152/ajpendo.1984.247.1.E53.
The application of radioligand binding techniques has recently led to increased understanding of adrenergic receptors, the recognition sites for catecholamines on target cells. Radioligand binding is a simple technique to conduct, although data obtained from binding studies are not always as easy to interpret as they are to generate. Nevertheless, the goal of these studies is to help define the molecular physiology of catecholamine action. In this article, I address five principal questions that largely dominate current research on adrenergic receptors. 1) How many types and subtypes of adrenergic receptors exist? 2) What is the structure of adrenergic receptors? 3) How is occupancy of adrenergic receptors translated to changes in target cell response? 4) How do target cells regulate their complement of adrenergic receptors? 5) Do alterations in adrenergic receptors mediate altered pathophysiology in disease? Although only preliminary answers are available, the use of radioligand binding methodology, together with other biochemical, cell biological, immunological, and molecular biological approaches should provide the tools to obtain definitive answers to those questions within the near future.
放射性配体结合技术的应用最近使人们对肾上腺素能受体有了更多的了解,肾上腺素能受体是靶细胞上儿茶酚胺的识别位点。放射性配体结合是一种易于实施的技术,尽管从结合研究中获得的数据并不总是像生成数据那样容易解释。然而,这些研究的目的是帮助确定儿茶酚胺作用的分子生理学。在本文中,我提出了五个主要问题,这些问题在很大程度上主导了当前对肾上腺素能受体的研究。1)肾上腺素能受体存在多少种类型和亚型?2)肾上腺素能受体的结构是什么?3)肾上腺素能受体的占据如何转化为靶细胞反应的变化?4)靶细胞如何调节其肾上腺素能受体的数量?5)肾上腺素能受体的改变是否介导疾病中病理生理学的改变?尽管目前只有初步答案,但放射性配体结合方法与其他生物化学、细胞生物学、免疫学和分子生物学方法的结合,应该能在不久的将来提供工具,以获得这些问题的确切答案。